For our friends in India, we kindly suggest the following sessions at this year's annual meeting in Boston, MA.
What are the areas of potential risks when undertaking global clinical trials in emerging markets?
What are the GCP quality trends in US and emerging countries?
Partnering and Outsourcing Challenges in India: The New Paradigm Shifts
Partnering and #outsourcing in India: Strategies for integrating diverse skills around operational deliverables.
A Regulatory Perspective of Biosimilars in Emerging Markets
What are similarities/differences in biosimilar regulatory requirements in APAC and Latin America?
Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.